{"version":"1.0","type":"link","title":"Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).","author_name":"Ogasawara A 외","author_url":"https://prs-insight.online/author/Ogasawara%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166845","thumbnail_width":1200,"thumbnail_height":630}